US FDA Drug Office Reorg Enters Homestretch With Leadership Nods For Three Clinical Offices

 
• By Sue Sutter
Birds_Wire
The rearranging is just about complete for US FDA's Office of New Drugs. • Source: Shutterstock

More from US FDA

More from Agency Leadership